General Information of Drug (ID: DMMSBW5)

Drug Name
LY-545694 Drug Info
Synonyms Lead iGluR5 antagonist (pain), Eli Lilly
Indication
Disease Entry ICD 11 Status REF
Neuropathic pain 8E43.0 Phase 2 [1]
Cross-matching ID
PubChem CID
53307207
TTD Drug ID
DMMSBW5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Discontinued Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NPS-846 DMNL1VM Cerebrovascular ischaemia 8B1Z Terminated [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Glutamate receptor ionotropic (GRI) TTDXZ24 NOUNIPROTAC Antagonist [2]

References

1 ClinicalTrials.gov (NCT00785577) A Study for Treatment of Pain in Patients With Diabetic Neuropathy.. U.S. National Institutes of Health.
2 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800019739)
3 Neuroprotective effects of NPS 846, a novel N-methyl-D-aspartate receptor antagonist, after closed head trauma in rats. J Neurosurg. 1998 Jun;88(6):1066-74.